Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › Texas › Dallas
Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali Dallas, TX keessatti
Qorannoo 9 Dhukkubbee Onkoloo Interstishiyali f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Namoota walitti qabaa jiraSadarkaa 3
- Baylor University Medical Center, Dallas
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Namoota walitti qabaa jiraSadarkaa 2
- Baylor University Medical Center, Dallas
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Namoota walitti qabaa jira
- Baylor University Medical Center, Dallas
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Texas Southwestern, Dallas
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Namoota walitti qabaa jiraSadarkaa 3
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
Namoota walitti qabaa jiraSadarkaa 2
- University of Texas Southwestern Medical Center, Dallas
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Namoota walitti qabaa jiraSadarkaa 2
- aTyr Investigative Site, Dallas
Qorannoo Dhukkubbee Onkoloo Interstishiyali magaalota biroo keessatti
- New York City, NYQorannoo 18
- Philadelphia, PAQorannoo 16
- Los Angeles, CAQorannoo 14
- Charleston, SCQorannoo 13
- Kansas City, KSQorannoo 13
- Durham, NCQorannoo 13
- Chicago, ILQorannoo 12
- Houston, TXQorannoo 12
- Aurora, COQorannoo 11
- Ann Arbor, MIQorannoo 11
- Salt Lake City, UTQorannoo 9
- Boston, MAQorannoo 9
Qorannoo biroo Dallas keessatti
- Saree OljooQorannoo 55
- Kansara Qara'a Non-Small CellQorannoo 52
- Kansara MetastatikiiQorannoo 42
- Cufama OnneeQorannoo 42
- Saree (Gosoota Hunda)Qorannoo 37
- Kansarii ProstateQorannoo 36
- Kansarii ColorectalQorannoo 33
- ObesityQorannoo 30
- Kansarii OvariiQorannoo 28
- Dhibee QaraQorannoo 27
- Dukkana BladderQorannoo 27
- Kansa EndometiriyaaliiQorannoo 24
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.